0001437749-24-011712.txt : 20240411 0001437749-24-011712.hdr.sgml : 20240411 20240411091429 ACCESSION NUMBER: 0001437749-24-011712 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 17 CONFORMED PERIOD OF REPORT: 20240410 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Unregistered Sales of Equity Securities ITEM INFORMATION: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240411 DATE AS OF CHANGE: 20240411 FILER: COMPANY DATA: COMPANY CONFORMED NAME: UNIVERSAL BIOSENSORS INC CENTRAL INDEX KEY: 0001279695 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 980424072 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-52607 FILM NUMBER: 24837265 BUSINESS ADDRESS: STREET 1: 1 CORPORATE AVENUE STREET 2: ROWVILLE CITY: VICTORIA STATE: C3 ZIP: 3178 BUSINESS PHONE: 613-9213-9000 MAIL ADDRESS: STREET 1: 1 CORPORATE AVENUE STREET 2: ROWVILLE CITY: VICTORIA STATE: C3 ZIP: 3178 8-K 1 ubi20240411_8k.htm FORM 8-K ubi20240411_8k.htm
false 0001279695 0001279695 2024-04-10 2024-04-10
--12-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
 
Date of report (Date of earliest event reported) April 10, 2024
 
Universal Biosensors, Inc.
(Exact Name of Registrant as Specified in Its Charter)
         
Delaware
  
000-52607
  
98-0424072
(State or Other Jurisdiction
of Incorporation)
  
(Commission
File Number)
  
(IRS Employer
Identification No.)
 
   
1 Corporate Avenue
Rowville, 3178, Victoria
Australia
Not Applicable
(Address of Principal Executive Offices)
(Zip Code)
 
+61 3 9213 9000
(Registrant’s telephone number, including area code)
 
Not Applicable
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
  
Trading
Symbol(s)
  
Name of each exchange
on which registered
         
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company ☒
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
 
 
 
Item 1.01
Entry into a Material Definitive Agreement.
 
Underwriting Agreement
 
On April 11, 2024, Universal Biosensors, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with an underwriter named in the Underwriting Agreement (the “Underwriter”), whereby the Company agreed to issue: (i) up to 66,666,667 shares of its common stock in the form of CHESS Depositary Interests (“CDIs”), each of which represents a beneficial interest of one (1) fully paid share of the Company’s common stock together with (ii) options to purchase CDI for an exercise price of A$0.20 and expiry date 3 (three) years from the date of issue (the “Offer Options”), with one (1) Offer Option attaching to each such CDI, in a transaction including a pro rata non-renounceable entitlement offer to eligible existing CDI holders (the “Entitlement Offer”) at a price of A$0.15 per CDI, and the Underwriter agreed to take up its full entitlement under the Entitlement Offer and fully underwrite the Entitlement Offer, which means that the Underwriter has agreed to subscribe for or procure others to subscribe for all securities (if any) not subscribed for by the Company’s eligible securityholders under the Entitlement Offer. The Underwriting Agreement additionally contemplates that, subject to approval of the Australian Securities Exchange Limited (“ASX”) and satisfaction of certain conditions, the Offer Options and the Underwriter Options (as defined below) will be listed and subsequently traded on the ASX. The Company expects to receive aggregate gross proceeds of approximately A$10 million in connection with the Entitlement Offer (excluding amounts to be raised upon exercise of the Offer Options).
 
Pursuant to the terms of the Underwriting Agreement, the Company agreed to issue to the Underwriter (or its nominee) up to 13,849,567 options (the “Underwriter Options”), as its underwriting fee in lieu of a cash underwriting fee of 5% of the underwritten amount of A$10 million, or A$0.5 million. The terms of the Underwriter Options are identical to the terms of the Offer Options. If the Underwriter Options are not issued to the Underwriter, the Company will be obligated to pay a cash underwriting fee of 6% of the underwritten amount of A$10 million, or A$0.6 million. The Company has also agreed to pay reasonable costs and expenses incurred by the Underwriter in relation to the Entitlement Offer, including legal fees and out-of-pocket expenses.
 
The Underwriting Agreement contains representations, warranties, and agreements of the Company, conditions to closing, indemnification obligations of the parties, termination provisions, and other terms and conditions in each case that are customary in agreements of this type.
 
The foregoing description of the Underwriting Agreement does not purport to be complete and is subject to, and qualified in its entirety by reference to, the full text of the Underwriting Agreement, which will be filed as an exhibit to the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ending June 30, 2024.
 
Item 3.02               Unregistered Sales of Equity Securities.
 
The information relating to the issuance of CDIs, the Offer Options, and the Underwriter Options (collectively, the “Securities”) in connection with the Entitlement Offer disclosed in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 3.02.
 
The issuance of CDIs and the Offer Options in the Entitlement Offer will be made in reliance upon the exemption from registration afforded by Regulation S promulgated under the Securities Act of 1933, as amended (the “Securities Act”). The issuance of the Underwriter Options will be made in reliance upon the exemption from registration afforded by Section 4(a)(2) of the Securities Act or Regulation S promulgated under the Securities Act. The issuance of CDIs underlying the Offer Options and the Underwriter Options will be made in reliance upon the exemption from registration afforded by Regulation S promulgated under the Securities Act.
 
 
 
 
Item 5.03               Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
 
On April 10, 2024, following stockholder approval at the Meeting (as defined below), the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment (the “Certificate of Amendment”) to the Company’s Amended and Restated Certificate of Incorporation, as amended to date, to increase the number of authorized shares of the Company’s common stock from 300,000,000 shares to 750,000,000 shares. The Certificate of Amendment became effective upon acceptance of the filing by the Secretary of State of the State of Delaware.
 
The foregoing description of the Certificate of Amendment does not purport to be complete and is subject to, and qualified in its entirety by reference to, the full text of the Certificate of Amendment, which is filed as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated herein by reference.
 
Item 5.07               Submission of Matters to a Vote of Security Holders.
 
On April 10, 2024, the Company held a special meeting of stockholders (the “Meeting”). At the Meeting, the Company’s stockholders voted on four (4) proposals, which are described in more detail in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on March 25, 2024 and approved each such proposal. Proposal 5 (the Adjournment Proposal) was not presented at the Meeting because there were sufficient votes to approve Proposals 1 through 4.
 
Set forth below are the matters the stockholders voted on and the final voting results.
 
Proposal No.
  
Proposal
  
Votes For
  
Votes Against
  
Abstentions
  
Broker Non-Votes
Proposal 1
  
Underwriter Options Proposal
  
52,880,699
  
2,603,610
  
55,808,640
  
—
Proposal 2
  
Placement CDIs Ratification Proposal
  
103,092,909
  
7,643,449
  
1,310,211
  
—
Proposal 3
  
Placement Options Proposal
  
102,831,014
  
7,908,449
  
1,307,106
  
—
Proposal 4
  
Authorized Shares Proposal
  
108,416,353
  
2,323,110
  
1,307,106
  
—
 
 
Item 8.01
Other Events.
 
On April 11, 2024 (April 11, 2024 in Australia), the Company commenced the delivery to the stockholders of the Company a written notice with respect to the Entitlement Offer, as required by the ASX Listing Rules. In accordance with Rule 135c(d) under the Securities Act, a copy of such notice is filed as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference in this Item 8.01.
 
 
 
 
Forward-Looking Statements
 
This current report contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the “safe harbor” created by those sections. All statements in this current report that are not based on historical fact are “forward-looking statements.” These statements may be identified by words such as “estimates,” “anticipates,” “projects,” “plans,” “strategy,” “goal,” or “planned,” “seeks,” “may,” “might,” “will,” “expects,” “intends,” “believes,” “should,” and similar expressions, or the negative versions thereof, and which also may be identified by their context. All statements that address the development of the events including but not limited to the Company’s closing of the Entitlement Offer, the expected gross proceeds from the Entitlement Offer, and the successful listing of the Offer Options and the Underwriting Options for trading on ASX are forward-looking statements. While management has based any forward-looking statements included in this current report on its current expectations, the information on which such expectations were based may change. Forward-looking statements involve inherent risks and uncertainties, which could cause actual results to differ materially from those in the forward-looking statements as a result of various factors, including, but not limited to, the following: volatility of the trading price of the Company’s common stock, ultimate allocation of the amounts relating to the Entitlement Offer and other risks ancillary to the Entitlement Offer, a possibility of denial of the Company’s listing application for the Offer Options and the Underwriter Options, general economic uncertainty, or the occurrence of any other risks, including any event, change or other circumstances that could give rise to the termination of the Underwriting Agreement or otherwise prevent the Entitlement Offer or any part thereof from completion. The Company urges you to consider those risks and uncertainties in evaluating its forward-looking statements. Readers are cautioned to not place undue reliance upon any such forward-looking statements, which speak only as of the date made. Except as otherwise required by the federal securities laws, the Company disclaims any obligation or undertaking to publicly release any updates or revisions to any forward-looking statement contained herein (or elsewhere) to reflect any change in its expectations with regard thereto, or any change in events, conditions, or circumstances on which any such statement is based.
 
Not an Offer or Sale. Ineligible Securityholders
 
This Current Report on Form 8-K does not constitute an offer to sell or a solicitation of an offer to buy any of the Securities, nor shall there be any offer or sale of the Securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.
 
No securityholders of the Company with a registered address outside of Australia or New Zealand, or who are, or who are acting for the benefit of, U.S. Persons are invited, or will be permitted, to participate in the Entitlement Offer or purchase the Securities. The Company has instituted procedures to prevent any person who is not a resident of Australia or New Zealand, or any person who is, or who is acting for the benefit of, a U.S. Person, from purchasing the Securities in the Entitlement Offer.
 
Item 9.01               Financial Statements and Exhibits.
 
(d) Exhibits.
 
Exhibit
Number 
  
Description
3.1
  
     
99.1
  
     
104
  
Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101)
 
 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
UNIVERSAL BIOSENSORS, INC.
     
Date: April 11, 2024
By:
/s/ Salesh Balak
   
Salesh Balak
   
Principal Financial Officer
 
 
 EX-3.1 2 ex_652385.htm EXHIBIT 3.1 ex_652385.htm

Exhibit 3.1

 

 

CERTIFICATE OF AMENDMENT TO THE
AMENDED AND RESTATED
CERTIFICATE OF INCORPORATION
OF UNIVERSAL BIOSENSORS, INC.

 

Universal Biosensors, Inc. (the “Corporation”), a corporation organized and existing under the General Corporation Law of the State of Delaware, hereby certifies as follows:

 

1.    This Certificate of Amendment (the “Certificate of Amendment”) amends the provisions of the Corporation’s Amended and Restated Certificate of Incorporation, as amended to date, filed with the Secretary of State of the State of Delaware on December 5, 2006. (the “Amended and Restated Certificate of Incorporation”).

 

2.    The first paragraph of Article FOURTH of the Amended and Restated Certificate of Incorporation is hereby deleted in its entirety and replaced with:

 

“FOURTH: The total number of shares of stock which the Corporation shall have authority to issue is seven hundred fifty-one million (751,000,000) shares of which the Corporation shall have authority to issue seven hundred fifty million (750,000,000) shares of Common Stock, each having a par value of one hundredth of one cent ($0.0001), and one million (1,000,000) shares of Preferred Stock, each having a par value of one cent ($0.01).”

 

3.    This amendment was duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware.

 

4.    All other provisions of the Amended and Restated Certificate of Incorporation shall remain in full force and effect.

 

 
 

 

IN WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment to be signed by Salesh Balak, its Chief Financial Officer, this April 11, 2024.

 

 

 

 

 

 

 

 

By:

/s/ Salesh Balak

 

 

Name:

Salesh Balak

 

 

Title:

Chief Financial Officer

 

 

 
 EX-99.1 3 ex_652386.htm EXHIBIT 99.1 ex_652386.htm

Exhibit 99.1

 

Universal Biosensors, Inc.

ARBN 121 559 993

 

1 Corporate Avenue

Rowville Victoria 3178

Australia

 

Telephone +61 3 9213 9000

Facsimile +61 3 9213 9099

Email info@universalbiosensors.com

www.universalbiosensors.com
ubilogo.jpg

 

 

11 April 2024

 

Dear Securityholder,

 

UNIVERSAL BIOSENSORS, INC. ARBN 121 559 993 - ENTITLEMENT OFFER - NOTIFICATION TO INELIGIBLE SECURITYHOLDERS OF ENTITLEMENT OFFER

 

Today Universal Biosensors, Inc. ARBN 121 559 993 (UBI or Company) announced a fully underwritten pro-rata non-renounceable entitlement offer of new CHESS depositary interests over fully paid ordinary shares (common stock) in UBI (New CDIs) to raise approximately A$10 million at a ratio of 1 New CDI for every 3.47 existing CDIs (Existing CDIs) held at 7:00pm (Melbourne time) on Tuesday, 16 April 2024 (Record Date) at an offer price of A$0.15 (Offer Price), together with 1 new attaching option for every New CDI acquired under the Entitlement Offer (New Options) (Entitlement Offer).

 

Eligible securityholders who take up their full entitlement may also apply for additional new CDIs (Additional New CDIs) together with 1 new option for each Additional New CDI acquired (Additional New Options) in excess of their entitlement under a top up facility at the same Offer Price (Top Up Facility). The Top Up Facility is not capped, however, to the extent that the Company receives valid applications in excess of the available Additional New CDIs and Additional New Options under the Top Up Facility, the Company reserves the right to scale back applications in its discretion, having regard to the pro rata entitlement of Eligible Securityholders who apply for Additional New CDIs and Additional New Options.

 

In this letter, each of the New CDIs, New Options, Additional New CDIs and Additional New Options are together, the Offer Securities.

 

Proceeds of the Entitlement Offer shall be applied to:

 

 

●

sustain growth;

 

 

●

support ongoing product development;

 

 

●

fund short term operating losses; and

 

 

●

operate and expand marketing and sales development, particularly in relation to the sale of UBI's Xprecia Prime device following its recent FDA approval.

 

Further details of the Entitlement Offer were announced to the ASX today, on Thursday, 11 April 2024.

 

This letter is to inform you about the Entitlement Offer, and to explain why you will not be eligible to subscribe for the Offer Securities under the Entitlement Offer. This letter is not an offer to issue Offer Securities to you, nor an invitation for you to apply for Offer Securities.

 

You are not required to do anything in response to this letter and you are not being invited, and will not be permitted, to participate in the Entitlement Offer or purchase securities sold in the Entitlement Offer. The Company has instituted procedures to prevent any person who is not a resident of Australia or New Zealand, or any person who is, or who is acting for the benefit of, a “U.S. Person” (within the meaning of Regulation S (Regulation S) promulgated under the U.S. Securities Act of 1933, as amended (U.S. Securities Act)), from purchasing securities offered or sold in the Entitlement Offer.

 

 
 

 

Eligibility Criteria

 

Securityholders who are eligible to participate in the Entitlement Offer (Eligible Securityholders) are those securityholders who:

 

 

●

are registered as a holder of Existing CDIs as at the Record Date;

 

 

●

have a registered address on the UBI share register in Australia or New Zealand as at the Record Date;

 

 

●

are not in the United States, its possessions and territories, any state thereof or the District of Columbia (United States), and are not, and are not acting for the account or benefit of, a U.S. Person, as defined in Regulation S under the U.S. Securities Act or a person elsewhere outside Australia or New Zealand; and

 

 

●

do not hold CDIs on behalf of another person who resides outside Australia or New Zealand (unless they hold CDIs in another eligible capacity).

 

UBI has determined, pursuant to ASX Listing Rule 7.7.1(a), that it would be unreasonable to make offers to securityholders with registered addresses in jurisdictions outside of Australia and New Zealand in connection with the Entitlement Offer (Ineligible Securityholders). This is due to legal and regulatory requirements in countries other than Australia and the potential costs to UBI of complying with these requirements compared with the relatively small number of securityholders in those countries, the relatively small number of Existing CDIs they hold, and the relatively low value of Offer Securities for which those securityholders would otherwise be entitled to subscribe.

 

Unfortunately, according to our records, you do not satisfy the eligibility criteria for an Eligible Securityholder as stated above. Accordingly, in compliance with ASX Listing Rule 7.7.1(b), UBI wishes to advise you that you are an Ineligible Securityholder and it will not be extending the Entitlement Offer to you and you will not be sent the Prospectus or be able to subscribe for Offer Securities under the Entitlement Offer.

 

As the Entitlement Offer is non-renounceable, you will not receive any payment or value for entitlements in respect of any Offer Securities that would have been offered to you if you were eligible.

 

Further Information

 

On behalf of the Board and management of UBI, we regret that you are not eligible to participate in the Entitlement Offer and thank you for your continued support of the Company.

 

Yours sincerely,

 

 

 

John Sharman

Chief Executive Officer

Universal Biosensors, Inc.

 

 

The offer and sale of the New CDIs, the Additional CDIs, the New Options, the Additional New Options, any CDIs received upon the exercise of New Options and Additional New Options and the shares of the Company’s common stock evidenced by any of the foregoing (collectively, the “Securities”), have not been and will not be registered under the U.S. Securities Act or the securities laws of any state or other jurisdiction of the United States. Offers and sales of the Securities are being made to investors outside the United States that are not, and are not acting for the account or benefit of, U.S. Persons (as defined in Regulation S) in accordance with the exemption from registration under the U.S. Securities Act provided by Regulation S, and the Securities will be “restricted securities” for purposes of Rule 144 under the U.S. Securities Act. Accordingly, the Securities may not be offered or sold in the United States or to, or for the account or benefit of, any U.S. Person, unless registered under the U.S. Securities Act and any other applicable securities laws of any state or other jurisdiction of the United States or an applicable exemption from such registration requirements is available. The New Options and the Additional New Options may not be exercised by or for the account or benefit of any U.S. Person unless registered under the U.S. Securities Act or an applicable exemption from such registration requirement is available. No holder of Securities will have the right to require the Company to register any of the Securities under the U.S. Securities Act or the securities laws of any state or other jurisdiction of the United States. Hedging transactions involving the Securities may not be conducted unless in compliance with the U.S. Securities Act.

 
 EX-101.SCH 4 ubi-20240410.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink EX-101.DEF 5 ubi-20240410_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 6 ubi-20240410_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity [Domain] Legal Entity [Axis] Document Information [Line Items] Document Information [Table] Current Fiscal Year End Date Document, Type Document, Period End Date Entity, Registrant Name Entity, Incorporation, State or Country Code Entity, File Number Entity, Tax Identification Number Entity, Address, Address Line One Entity, Address, City or Town Entity, Address, Postal Zip Code Entity, Address, Address Line Two Entity, Address, Country City Area Code Local Phone Number Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Entity, Emerging Growth Company Entity, Ex Transition Period Amendment Flag Entity, Central Index Key EX-101.PRE 7 ubi-20240410_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 8 ubilogo.jpg begin 644 ubilogo.jpg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end XML 10 R1.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Document And Entity Information
Apr. 10, 2024
Document Information [Line Items]  
Entity, Registrant Name Universal Biosensors, Inc.
Current Fiscal Year End Date --12-31
Document, Type 8-K
Document, Period End Date Apr. 10, 2024
Entity, Incorporation, State or Country Code DE
Entity, File Number 000-52607
Entity, Tax Identification Number 98-0424072
Entity, Address, Address Line One 1 Corporate Avenue
Entity, Address, City or Town Rowville
Entity, Address, Postal Zip Code 3178
Entity, Address, Address Line Two Victoria
Entity, Address, Country AU
City Area Code 61
Local Phone Number 3 9213 9000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity, Emerging Growth Company true
Entity, Ex Transition Period false
Amendment Flag false
Entity, Central Index Key 0001279695
EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 12 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 15 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.u1 html 1 22 1 false 0 0 false 0 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.ubi.com/20240410/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false All Reports Book All Reports ubi-20240410.xsd ubi-20240410_def.xml ubi-20240410_lab.xml ubi-20240410_pre.xml ubi20240411_8k.htm http://xbrl.sec.gov/dei/2023 true false JSON 17 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "ubi20240411_8k.htm": { "nsprefix": "ubi", "nsuri": "http://www.ubi.com/20240410", "dts": { "schema": { "local": [ "ubi-20240410.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] }, "definitionLink": { "local": [ "ubi-20240410_def.xml" ] }, "labelLink": { "local": [ "ubi-20240410_lab.xml" ] }, "presentationLink": { "local": [ "ubi-20240410_pre.xml" ] }, "inline": { "local": [ "ubi20240411_8k.htm" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 26, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 22 }, "report": { "R1": { "role": "http://www.ubi.com/20240410/role/statement-document-and-entity-information", "longName": "000 - Document - Document And Entity Information", "shortName": "Document And Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "d20248K", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ubi20240411_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d20248K", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ubi20240411_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.ubi.com/20240410/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.ubi.com/20240410/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.ubi.com/20240410/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://www.ubi.com/20240410/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "lang": { "en-us": { "role": { "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.ubi.com/20240410/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document, Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.ubi.com/20240410/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document, Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.ubi.com/20240410/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://www.ubi.com/20240410/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.ubi.com/20240410/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://www.ubi.com/20240410/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.ubi.com/20240410/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.ubi.com/20240410/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r0" ] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityDomain", "presentation": [ "http://www.ubi.com/20240410/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity [Domain]", "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.ubi.com/20240410/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r0" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://www.ubi.com/20240410/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r5" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.ubi.com/20240410/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.ubi.com/20240410/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.ubi.com/20240410/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r0" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.ubi.com/20240410/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r0" ] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LegalEntityAxis", "presentation": [ "http://www.ubi.com/20240410/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.ubi.com/20240410/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.ubi.com/20240410/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r1" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.ubi.com/20240410/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.ubi.com/20240410/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.ubi.com/20240410/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r4" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 18 0001437749-24-011712-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-24-011712-xbrl.zip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ubi20240411_8k_htm.xml IDEA: XBRL DOCUMENT 0001279695 2024-04-10 2024-04-10 false 0001279695 --12-31 8-K 2024-04-10 Universal Biosensors, Inc. DE 000-52607 98-0424072 1 Corporate Avenue Rowville 3178 Victoria AU 61 3 9213 9000 false false false false true false